Nutter presents Acceleration 2013 Early Stage Life Sciences ConferencePrint PDF
Nutter is presenting Acceleration 2013, the firm’s Early Stage Life Sciences Conference, with Halloran Consulting Group and Silicon Valley Bank on December 9. This annual invitation only event connects investors, entrepreneurs and industry executives in biotech, pharma, device and healthcare who are focused on innovation and investment for growth. Key thought leaders will examine exit transactions and how the industry views value creation in a post-ACA world.
Monday, December 9, 2013, 3:30-6:40 p.m.
Nutter McClennen & Fish LLP
Louis D. Brandeis Conference Center
155 Seaport Boulevard, Boston
Healthcare: Trends in Mergers and Acquisitions
Silicon Valley Bank
Jonathan Norris will present findings from Silicon Valley Bank’s annual report on healthcare venture trends, examining early stage investment, venture fundraising, exit deals, and industry forecasts.
For a copy of Jonathan's presentation Healthcare Venture: State of the Industry Update, click here.
PANEL: EXITS FOR LIFE SCIENCE COMPANIES
How the Affordable Care Act is changing the definition of value for entrepreneurs, investors and acquirers. The panel will explore the impact of the ACA – with its focus on patient outcomes and cost control – on the building, financing and acquisition of life science companies.
Bessemer Venture Partners
Michael Powell, PhD
Senior Director, Health Economics and Reimbursement
INTERVIEW WITH CEO
Barbara Fox, Ph.D., Founder & CEO of Avaxia Biologics, will be interviewed by Angel investor and Board Member, Henry Kay, to describe the challenges faced, and solutions identified, in conceptualizing, funding and growing a cutting edge biotechnology company.
The program will be followed by cocktails and networking. To view the full agenda for this invitation only event, click here.